Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs

Journal Article · · American Journal of Physiology; (USA)
OSTI ID:7018851
; ; ;  [1]
  1. Vanderbilt Univ. School of Medicine, Nashville, TN (USA)
The effects of somatostatin plus intraportal insulin and glucagon replacement (pancreatic clamp) on carbohydrate metabolism were studied in conscious dogs fasted for 7 days so that gluconeogenesis was a major contributor to total glucose production. By use of (3-{sup 3}H)glucose, glucose production (R{sub a}) and utilization (R{sub d}) and glucose clearance were assessed before and after implementation of the pancreatic clamp. After an initial control period, somatostatin (0.8 {mu}g{center dot}kg{sup {minus}1}{center dot}min{sup {minus}1}) was infused with intraportal replacement amounts of glucagon and insulin. The insulin infusion rate was varied to maintain euglycemia and then kept constant for 250 min. Plasma glucagon was similar before and during somatostatin infusion, while plasma insulin was lower. Plasma glucose levels remained similar while R{sub a} and R{sub d} and the ratio of glucose clearance to plasma insulin were significantly increased. Net hepatic lactate uptake and ({sup 14}C)alanine plus ({sup 14}C)lactate conversion to ({sup 14}C)glucose increased. In conclusion, somatostatin alters glucose clearance in 7-day fasted dogs, resulting in changes in several indices of carbohydrate metabolism.
OSTI ID:
7018851
Journal Information:
American Journal of Physiology; (USA), Journal Name: American Journal of Physiology; (USA) Vol. 253:4; ISSN 0002-9513; ISSN AJPHA
Country of Publication:
United States
Language:
English